364 related articles for article (PubMed ID: 3010600)
1. [Malignancy grading of glial tumors. I. Astrocytomas].
Martin H; Schmidt D
Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
[TBL] [Abstract][Full Text] [Related]
2. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
3. Grading of astrocytomas. A simple and reproducible method.
Daumas-Duport C; Scheithauer B; O'Fallon J; Kelly P
Cancer; 1988 Nov; 62(10):2152-65. PubMed ID: 3179928
[TBL] [Abstract][Full Text] [Related]
4. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
[TBL] [Abstract][Full Text] [Related]
5. Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases.
Labrousse F; Daumas-Duport C; Batorski L; Hoshino T
J Neurosurg; 1991 Aug; 75(2):202-5. PubMed ID: 1649271
[TBL] [Abstract][Full Text] [Related]
6. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
7. Grading astrocytomas.
Adelman LS
Neurosurg Clin N Am; 1994 Jan; 5(1):35-41. PubMed ID: 8124092
[TBL] [Abstract][Full Text] [Related]
8. Gemistocytic astrocytomas: a reappraisal.
Krouwer HG; Davis RL; Silver P; Prados M
J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
[TBL] [Abstract][Full Text] [Related]
9. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
[TBL] [Abstract][Full Text] [Related]
10. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system.
Wang HC; Ho YS
J Neurooncol; 1992 Jul; 13(3):265-76. PubMed ID: 1325543
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity and histopathological features in diffuse grade II astrocytomas.
Lind-Landström T; Habberstad AH; Torp SH
APMIS; 2012 Aug; 120(8):640-7. PubMed ID: 22779687
[TBL] [Abstract][Full Text] [Related]
13. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of tumour vessels in cytological squash smears of astrocytic tumours.
Sato S; Sato Y; Marutsuka K; Takeshima H; Asada Y
Cytopathology; 2011 Oct; 22(5):313-7. PubMed ID: 21039979
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in astrocytomas with different grades of malignancy.
Yew DT; Wang HH; Zheng DR
Acta Neurochir (Wien); 1998; 140(4):341-7. PubMed ID: 9689325
[TBL] [Abstract][Full Text] [Related]
18. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
19. Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors.
Zaprianov Z; Christov K
Cytometry; 1988 Jul; 9(4):380-6. PubMed ID: 2841078
[TBL] [Abstract][Full Text] [Related]
20. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
Klein R; Roggendorf W
Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]